NE3107 in Adults With Neurological Symptoms of Long COVID

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(20 sites)

United States

Stanford University, Palo Alto, California

UCSF, San Francisco, California

University of Colorado, Aurora, Colorado

Yale University, New Haven, Connecticut

Clinical Trial Site, Jacksonville, Florida

Centricity Research, Columbus, Georgia

Illinois Research Network University of Illinois at Chicago, Chicago, Illinois

Northwestern University, Chicago, Illinois

University of Iowa, Iowa City, Iowa

Norton Infectious Disease Institute, Louisville, Kentucky

Jadestone Clinical Research, Silver Spring, Maryland

Clinical Trial Site, Farmington Hills, Michigan

Mayo Clinic, Rochester, Minnesota

Icahn School of Medicine at Mount Sinai, New York, New York

University Hospitals Cleveland Medical Center, Cleveland, Ohio

Zenos Clinical Research, Dallas, Texas

University of Texas health Science Center at San Antonio, San Antonio, Texas

Chronicle Bio Inc., Park City, Utah

Swedish Center for Research and Innovation, Seattle, Washington

West Virginia University, Morgantown, West Virginia